OSUR Orasure Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OSUR

Price (delayed)

$4.14

Market cap

$285.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.04

Enterprise value

$120.73M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 19
Relative Profitability: Rel. Profitability: 14

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides ...

Highlights
Orasure Technologies's debt has decreased by 11% YoY and by 4.1% QoQ
OSUR's EPS has shrunk by 148% YoY and by 11% QoQ
OSUR's net income has dropped by 135% year-on-year and by 9% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.orasure.com
Peers: COO QDEL DGX BIO

Key stats

What are the main financial stats of OSUR

OSUR stock price

How has the Orasure Technologies stock price performed over time
Intraday
4.81%
1 week
-2.13%
1 month
40.34%
1 year
42.76%
YTD
71.07%
QTD
38%

Financial performance

How have Orasure Technologies's revenue and profit performed over time
Revenue
$113.02M
Gross profit
$47.7M
Operating income
-$77.49M
Net income
-$75.07M
Gross margin
42.2%
Net margin
-66.4%
OSUR's operating margin has shrunk by 193% YoY and by 10% QoQ
OSUR's net income has dropped by 135% year-on-year and by 9% since the previous quarter
Orasure Technologies's operating income has shrunk by 105% YoY and by 8% QoQ
Orasure Technologies's revenue has decreased by 30% YoY

Price vs fundamentals

How does OSUR's price correlate with its fundamentals

Growth

What is Orasure Technologies's growth rate over time

Valuation

What is Orasure Technologies stock price valuation
OSUR P/E details
P/E
N/A
P/B
0.91
P/S
2.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.07
OSUR's EPS has shrunk by 148% YoY and by 11% QoQ
The P/B is 45% above the last 4 quarters average of 0.6 but 13% below the 5-year quarterly average of 1.0
The company's equity fell by 21% YoY and by 8% QoQ
OSUR's price to sales (P/S) is 53% higher than its 5-year quarterly average of 1.6 and 44% higher than its last 4 quarters average of 1.7
Orasure Technologies's revenue has decreased by 30% YoY

Efficiency

How efficient is Orasure Technologies business performance
OSUR's return on invested capital has dropped by 190% year-on-year and by 17% since the previous quarter
The return on equity has dropped by 179% year-on-year and by 16% since the previous quarter
The ROA has plunged by 168% YoY and by 14% from the previous quarter
OSUR's ROS is down by 11% QoQ

Dividends

What is OSUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OSUR.

Financial health

How did Orasure Technologies financials performed over time
The quick ratio has shrunk by 57% YoY and by 18% QoQ
Orasure Technologies's current ratio has shrunk by 56% YoY and by 17% QoQ
Orasure Technologies's debt is 96% lower than its equity
The company's equity fell by 21% YoY and by 8% QoQ
Orasure Technologies's debt has decreased by 11% YoY and by 4.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.